Services at a Glance
Axumin ® PET/CT Scan
An Axumin PET/CT Scan is a diagnostic imaging study that offers the latest technology in the early detection and localization of recurrent prostate cancer. The FDA-approved, Medicare-covered diagnostic Axumin PET/CT Scan pinpoints the specific location of the cancer and provides insight into the disease process itself.
Lung Cancer Screening
Our low dose screening program is designed to try to catch the lung cancer at an earlier, more treatable stage, thereby saving lives. Annual screening programs, starting at age 55 years and ending at age 80 years, among current or former smokers with a 30 pack-year smoking history, detect 50% of lung cancers earlier.